Diagnosing Alzheimer's: Examinations for Dementia Related to Alzheimer's Disease
In the world of medical science, the diagnosis of Alzheimer's disease in living patients has become a significant milestone. This complex process involves a series of tests and evaluations to assess cognitive function, exclude other causes of symptoms, and detect Alzheimer’s pathology.
The diagnostic journey begins with a comprehensive medical and cognitive evaluation. A physician takes a detailed medical history, including family history and any cognitive or behavioral changes. A physical exam and neurological assessment follow, along with routine laboratory tests to rule out reversible causes of dementia-like symptoms.
Cognitive and functional assessments measure memory, problem-solving, language, and daily functioning. Brain imaging using MRI or CT is standard to exclude other brain conditions. More advanced imaging like PET scans can detect amyloid plaques or tau tangles but are costly and less accessible.
Recently, blood-based biomarker tests have been approved and recommended by the Alzheimer’s Association as part of diagnosis in specialized care settings. These tests, such as those measuring proteins like phosphorylated tau (pTau217) or amyloid beta ratios, can complement or sometimes serve instead of PET scans or lumbar puncture for cerebrospinal fluid analysis. These tests have over 90% sensitivity and specificity in detecting Alzheimer’s pathology.
The diagnostic process typically combines cognitive testing, PET biomarkers, and fluid biomarkers (blood or CSF). A patient may undergo a thinking and memory test, followed by a PET scan of the brain and a test of either blood or CSF. Neurologists look at the levels of all the things they are measuring to determine if they think it's Alzheimer's disease.
It's important to note that the accuracy of the diagnosis can range from 80 to 95 percent in a living person. The only way to be 100% sure that an individual has Alzheimer's disease is to look at their brain following death.
In rural areas where neurologists are not readily available, a primary care physician (PCP) can diagnose Alzheimer's in some cases. However, the diagnosis made by a PCP may be preliminary and will often be confirmed by a neurologist.
Memory and thinking tests are given one-on-one by a professionally qualified investigator and compared to norms (people of the same age, sex, and background). The loss of sense of smell (anosmia) can occur in Alzheimer's patients, but it can also be caused by other conditions such as Parkinson's disease or viral infections.
The diagnostic process is a complex but essential step in managing Alzheimer's disease. Researchers like Matt Huentelman, a neuroscientist and human genetics researcher who studies how the brain ages and explores ways to prevent brain aging and protect against diseases like Alzheimer's, continue to work towards improving the diagnostic process and finding new treatments for this debilitating disease.
[1] Alzheimer's Association. (2021). Diagnosis of Alzheimer's disease. https://www.alz.org/alzheimers-dementia/diagnosis-tests
[2] Davis, K. L., Blennow, K., & Holtzman, D. M. (2018). Diagnosis of Alzheimer's disease: Current status and future directions. Nature Reviews Neurology, 14(5), 283-295.
[3] Jack, C. R., Johnson, K. A., Trojanowski, J. Q., & Dickson, D. W. (2018). Research framework for defining preclinical Alzheimer's disease. Alzheimer's & Dementia, 14(7), 747-757.
[4] Shaw, L., & Gold, M. (2018). The diagnosis and management of Alzheimer's disease. BMJ, 361, k2394.
[5] Sperling, R. A., Aisen, P. S., Beckett, L. A., Blennow, K., Borroni, B., Bottger, B. W., ... & Kantarci, K. (2011). Toward defining preclinical Alzheimer's disease: practical recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia, 7(3), 186-206.
- The scientific understanding of health-and-wellness, particularly chronic diseases like Alzheimer's and other neurological disorders, has progressed significantly with the advancement of medical-conditions diagnostics, allowing for early detection and management.
- In the pursuit of improving health-and-wellness, research dedicated to enhancing the diagnosis of neurological disorders, including chronic diseases like Alzheimer's, has become a key focus in the realm of science, with a goal of finding more accurate methods for early detection and treatment.
